Dear Industry Friends
HHopefully first month of new financial year 2022-23 must have been very hectic and strategic for all of you. Post pandemic FY 2022-23 poses enormous challenges as well as opportunities for healthcare industry which has been gradually gravitating back towards pre-pandemic confidence level. Post pandemic, sector agnostic economic recovery imperatives are two folds: reconciliatory affordability across value chain to encourage consumption and commensurate production. The other economic reconciliatory imperative is is reaching out export market to deepen business sustainability depth.
Indian healthcare and MedTech are no different for these economic recovery imperatives.
I would like to compliment Singapore based Times Medical Systems, first indigenous MRI manufacturer for repeating their global mission of manufacturing and marketing affordably priced MRI with affordable maintenance cost in Indian market too.
With affordable and customised versions to cater neonatal, breast cancer and neuro imaging needs, Times Medical would enhance radiology penetration and quality of care across all tiers of Indian market.
No doubt, Make in India , PLI and Semi-Conductor manufacturing policy proactiveness has come of age, from early years of policy procrastination, and has started catalysing indigenous manufacturing in healthcare too.
I am also pleased to inform you that we have resumed physical MT India Healthcare Awards this year. I humbly and cordially invite you to attend 12th MT India Healthcare Awards 2022 Night on 20th May 2022, at 110 Convention Centre, BKC , Mumbai during India's biggest Medical exhibition Medical Fair India scheduled 20th-22nd May 2022.
I extend my best wishes for Fabulous Financial Year 2022 to all of you!
Have an insightful reading. Your suggestions are most welcome! E-mail: editor@medgatetoday.com Website: www.medgatetoday.com